2nd Edition · PDDS 2018

June 4–6, 2018 · Rome, Italy

62Speakers
64Presentations
31Countries

About PDDS 2018

We had a huge success with the completion of “2nd Edition of Global Conference on Pharmaceutics and Drug Delivery Systems” slated during June 04-06, 2018 at the beautiful city of Rome, Italy. The congress was based on the theme “The multifaceted aspects of drug delivery.” 

The scientific gathering’s significance was reached via the gathering of all linked groups of research scientists to exchange their knowledge, research effort, technologies, and moreover trade of global information to the right crowd at the right moment. This congress has gotten a lot of positive feedback from all over the world. This event was held with the goal of encouraging the creation of fresh perspectives and ideas for studying the scientific community's high level of knowledge in the field of pharmaceutical sciences and drug delivery systems. It also featured timely keynote addresses, oral presentations, poster presentations, and exhibitions.

This strategic conference had in-depth plenary talks and interactive sessions that allowed attendees to network with like-minded individuals and discuss how to tackle current obstacles in pharmaceutical product development and synthesis.  We appreciate the continued support and participation of all of our Organizing Committee Members, Keynote Speakers, Speakers, Delegates, and all well-wishers at the PDDS 2018. Various scientific sessions and entire presentations were used to organise the conference proceedings. We owe a huge debt of gratitude to all of the participants for helping us to strengthen the research community and making this event a great success.

Scientific Program

Day 114 presentations

  1. Next generation of drug delivery system: Stimuli-sensitive combination nanopreparations

    Vladimir P. Torchilin · Northeastern University

  2. Drug screening and targeting against the stem subpopulation of cancer cells

    Esmaiel Jabbari · University of South Carolina

  3. Targeting nanomedicine to the vascular endothelium

    Vladimir Muzykantov · University of Pennsylvania the Perelman School of Medicine

  4. Nanoparticle delivery of mitochondria-associated microRNA regulating inflammation in the central nervous system

    Joe E. Springer · University of Kentucky

  5. Signaling peptides for brain diseases: Delivery and action

    Eugenia V Gurevich · Vanderbilt University

  6. Understanding the Impact of nanoparticle structure on cellular response

    Georgina Kate Such · The University of Melbourne

  7. Overcoming the barriers to effective targeted drug delivery through stem cell-derived nano-ghosts

    Marcelle Machluf · Technion – Israel Institute of Technology

  8. Chimeric and multicompartment drug delivery systems: Lessons learned and future perspectives

    Natassa Pippa · University of Athens

  9. Delivery of siRNA in vivo to the liver using redox sensitive and ionizable lipids

    Daniel Zucker · NOF Europe GmbH

  10. Getting health allies from agriculture enemies: Plant viruses as smart nanoparticles for vaccine/drug delivery

    Selene Baschieri · Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA)

  11. The influence of gut microbiota-mediated bile acid metabolism on the cellular response to therapeutics at the intestinal barrier

    Elaine Frances Enright · University College Cork

  12. Cyclodextrin-based photoactive liposomal nanoparticles for tumor targeting

    Ilya Yakavets · Universite de Lorraine

  13. ?rabinogalactan and Glycyrrhizic acid as promising agents for oral drug delivery

    Mikhail V. Khvostov · N.N. Vorozhtsov Institute of Organic Chemistry SB RAS

  14. Polyethylenimine-based nanoparticles decorated with small molecules mimicking RGD peptide for targeted plasmid DNA delivery

    Ali Dehshahri · Shiraz University of Medical Sciences

Day 231 presentations

  1. Physicochemical characterization of co-crystals and cyclodextrin inclusion complexes of bioactive molecules

    Mino R. Caira · University of Cape Town

  2. Peptide Delivery to the brain: A novel treatment for migraine

    Gillian Hutcheon · Liverpool John Moores University

  3. Lipid based parenteral depots for biomolecules, an update on recent work

    Gerhard Winter · LMU Munchen

  4. The effects of drug encapsulation into gellan gum matrix by the example of roxithromycin, naproxen and meloxicam Tomasz Osmalek

    Tomasz Osmalek · Poznan University of Medical Sciences (PUMS)

  5. 5-Tiered (pre-) formulation approach to support toxicology studies

    Marc Du Jardin · Janssen

  6. Porous biodegradable particles for efficient transfollicular drug delivery

    Yulia Svenskaya · Saratov State University

  7. Novel RNA-carbohydrate conjugates for modulation of LDLR and cholesterol by transcriptional silencing

    Kira Astakhova · University of Southern Denmark

  8. Myometrium-targeted liposomes for prevention of preterm labor

    Biana Godin · Houston Methodist Research Institute

  9. Poly (vinyl pyrrolidone) nanofibers as drug delivery of sildenafil citrate

    Luis Jesus Villarreal Gomez · Universidad Autónoma de Baja California

  10. The reversal of type 2 diabetes - The role of the Bile acids

    Gerald H Tomkin · Beacon Hospital and Trinity College Dublin

  11. New potential nanotechnology-based therapy with novel Gal-3 inhibitor for the treatment of rheumatoid arthritis

    Nataliya Storozhylova · University of Santiago de Compostela

  12. New aerosol treatment for human nasal cavity through numerical simulation

    Hadrien Calmet · Barcelona Supercomputing Center (BSC-CNS)

  13. Numerical evaluation of exhalation through the nose treatment for eosinophilic chronic Rhinosinusitis using computational fluid dynamics

    Takahisa yamamoto · National Institute of Technology, Gifu College

  14. Case presentation: Patient with metastatic pancreatic adenocarcinoma treated with nanoliposomal irinotecan combination therapy

    Matej Dobravc Verbic · University Medical Centre Ljubljana

  15. Nanostructured biomaterials and technologies for bone regeneration

    Marcelo Nacucchio · University of Buenos Aires

  16. Brain targeted nanotherapeutics: An enticing journey from ideation to product realization Vandana B Patravale

    Vandana B. Patravale · Institute of Chemical Technology

  17. Investigations on the cytotoxic effect of gold nanoparticles synthesized using Ferulic acid on human epidermoid carcinoma (A431) cells

    Lonchin Suguna · Central Leather Research Institute

  18. Challenges of in vitro drug release testing in case of advanced mucosal formulations

    Mario Jug · University of Zagreb

  19. Discovering multiple drug binding sites and modes with Wrap ‘n’ Shake

    Monika Eniko Balint · University of Pecs

  20. Thermoresponsive nanocarriers for doxorubicin delivery combined with hyperthermia

    Ilya Yakavets · Universite de Lorraine

  21. In vivo siRNA delivery in whitefish: siRNA uptake and the efficacy of gene expression silencing

    Pawel Brzuzan · University of Warmia and Mazury in Olsztyn

  22. Unnatural amino acids derived peptidomimetics with potent anti-biofilm activity

    Jeong Kyu Bang · Korea Basic Science Institute

  23. Poly(glycolide-?-caprolactone) and poly(glycolide-?-caprolactone-D,L-lactide) coatings enriched with ciprofloxacin formed on metallic implants

    Joanna Jaworska · Polish Academy of Sciences

  24. Dual-targeted biodegradable micelles for anticancer drug delivery

    Katarzyna Jelonek · Polish Academy of Sciences

  25. PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer

    Hyung Jun Ahn · Korea Institute of Sceince and Technology

  26. Non-invasive method for screening drug penetration in skin using different dermal drug delivery systems by Raman microscopy

    Attila Gacsi · University of Szeged

  27. Eucommia ulmoides ameliorates glucotoxicity by suppressing advanced glycation endproducts in diabetic mice kidney

    Sang Keun Ha · Korea Food Research Institute

  28. Study of penetration and analgesic and antiinflamatory effects of indomethacin nanoemulsion

    Anayanti Arianto · University of Sumatera Utara

  29. Quality evaluation of rifaximin tablets by an eco-friendly spectrophotometric method in the ultraviolet region

    Ana Carolina Kogawa · Univ Estadual Paulista – UNESP

  30. Radiolabeled drug/ligand loaded Micelles: Exploring diagnostic and therapeutic potentials for glioma through the intranasal route

    Prashant G. Upadhaya · Institute of Chemical Technology

  31. The most sensitive neurodevelopmental period for the effects of methamphetamine on creating predisposition to drug addiction in adulthood

    Ivana Hrebickova · Charles University

Day 319 presentations

  1. Impact of inhalation manoeuvre parameters on drug delivery to the Lungs from dry powder inhalers in-vitro and Ex-vivo

    El Hassane Larhrib · University of Huddersfield

  2. Flexible analyses of population-based pharmaco-epidemiological studies of comparative effectiveness and safety of drugs

    Michal Abrahamowicz · McGill University

  3. HEA-HEMA hydrogels: Composition effect on physicochemical and pharmaceutical properties

    Irina Ermolina · De Montfort University School of Pharmacy

  4. Cyclic GMP-AMP: A new hope for metabolic disease?

    Chaodong Wu · Texas A&M University

  5. Computational blind docking of ligands to drug targets: Methodology and applications

    Csaba Heteny · University of Pecs

  6. The competitive binding studies of CMP inhibitor and polysialic acid (polySia) to the polybasic polysialyltransferase domain (PSTD) in the polysialyltransferase

    Guo-Ping Zhou · Guangxi Academy of Sciences

  7. The main trends in the developing novel therapeutics for alzheimer’s disease treatment

    Sergey Bachurin · Russian Academy of Sciences

  8. Casein-based nanovehicles for oral delivery of chemotherapeutic combinations to overcome multidrug resistance in gastric cancer

    Maya Bar-Zeev · Technion – Israel Institute of Technology

  9. Use of an inflating agent to engineer novel lactose carrier for inhalation and drug deposition in-vitro using three model drugs: Salbutamol, beclomethasone and fluticasone

    Ursula Thevarajah · University of Huddersfield

  10. Characterization of lactose carrier for dry powder inhaler formulations

    Faiza Naseer · University of Huddersfield

  11. EAAT3 proteins as a pharmacological target for the design of new antiepileptic drugs

    Lourdes Amable Vega Rasgado · Escuela Nacional de Ciencias Biologicas del Instituto Politecnico Nacional

  12. Hard alginate capsules shell as enteric capsules

    Hakim Bangun · University of Sumatera Utara

  13. Synthesis and cytotoxicity studies on novel piperazinylacetamides

    Enise Ece Gurdal · Yeditepe University

  14. Stability studies on the formulations of inclusion complex of tenoxicam in SBE7 ? cyclodextrin and beta cyclodextrin

    K.V.R.N.S.Ramesh · RAK Medical & Health Sciences University

  15. Development and evaluation of self micro emulsifying drug delivery systems of itraconazole

    Hemant K. S. Yadav · RAK Medical & Health Science University

  16. Microbiological pharmaceutical analysis: Better safe than sorry

    Ana Carolina Kogawa · Univ Estadual Paulista – UNESP

  17. Nature of naproxen enantiomers medicinal activity difference. Study by using model systems and modern physical methods.

    Tatyana V. Leshina · Voevodsky Institute of Chemichal Kinetics and Combustion SB RAS

  18. Nanoparticles in receptor-mediated drug delivery to brain parenchyma

    Mehrdad Azarmi Aghajan · Shahid Beheshti University

  19. Methotrexate induced liver and renal toxicity management by cornus mas: Back to nature antioxidants in fighting drug side effects

    Hassan Saeiahan · Iran University of Medical science

View the full 2018 program →

Speakers

Biana Godin

Biana Godin

Houston Methodist Research Institute · United States

Irina Ermolina

Irina Ermolina

De Montfort University School of Pharmacy · United Kingdom

Selene Baschieri

Selene Baschieri

Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA) · Italy

Maya Bar-Zeev

Maya Bar-Zeev

Technion – Israel Institute of Technology · Israel

K.V.R.N.S.Ramesh

K.V.R.N.S.Ramesh

RAK Medical & Health Sciences University · United Arab Emirates

Ali Dehshahri

Ali Dehshahri

Shiraz University of Medical Sciences · Iran (Islamic Republic of)

Hassan Saeiahan

Hassan Saeiahan

Iran University of Medical science · Iran (Islamic Republic of)

Mario Jug

Mario Jug

University of Zagreb · Croatia (Hrvatska)

Pawel Brzuzan

University of Warmia and Mazury in Olsztyn · Poland

Mikhail V. Khvostov

N.N. Vorozhtsov Institute of Organic Chemistry SB RAS · Russian Federation

Tatyana V. Leshina

Voevodsky Institute of Chemichal Kinetics and Combustion SB RAS · Russian Federation

Hyung Jun Ahn

Korea Institute of Sceince and Technology · Korea, Republic of

Sang Keun Ha

Korea Food Research Institute · Korea, Republic of

All 2018 speakers →

Scientific Committee

All 2018 committee members →

Gallery

All 78 photos from PDDS 2018 →

Downloads

14th Edition · PDDS 2027

September 13–15, 2027 · Olympia Hotel, Events & Spa, Valencia, Spain. Registration and abstract submission are open.

Register for PDDS 2027 →

Join the PDDS 2027 delegation

Valencia · September 13–15, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.